New clinical data for Gelita's Verisol

Alongside its established anti-wrinkle benefits, Geilta’s VERISOL collagen peptides are now proven to enhance skin hydration.

VERISOL® has a positive impact on skin health (Image: Gelita)

 VERISOL®, the patented and renowned collagen peptide for beauty-from-within, has once again demonstrated its positive impact on skin health. A recent randomised, double-blind, placebo-controlled clinical trial reaffirmed its known benefits of reducing wrinkles and boosting skin elasticity. The study also unveiled a new achievement – improved skin hydration. 

This latest study, conducted over eight weeks, reveals that VERISOL® delivers a significant increase in skin hydration in just four weeks. The positive clinical effects on wrinkle volume reduction, increased skin elasticity and hydration were even more pronounced after eight weeks. These results showcase the comprehensive and transformative nature of VERISOL®. 

A positive effect on skin’s extracellular matrix

Further strengthening its position as a beauty industry game-changer, experiments with human skin cells demonstrated that VERISOL® supplementation leads to a statistically significant increase in the skin’s extracellular matrix biosynthesis. This includes essential elements such as collagen, elastin, hyaluronic acid and proteoglycans. The observed stimulatory effect on the skin’s extracellular matrix provides a plausible explanation for the consistently positive clinical outcomes. 

It is noteworthy that these compelling clinical and in vitro results were achieved with VERISOL® derived from bovine sources. Importantly, this study affirms that the efficacy of VERISOL® from bovine sources is parallel with previously studied VERISOL® sourced from porcine origins. 

Changing the face of beauty

Lara Niemann, GELITA’s beauty category manager, emphasises the significance of these findings.

“Skin hydration is a prevailing consumer need. VERISOL® now offers clinical substantiation on this parameter in addition to reduced wrinkles and increased elasticity. With a low 2.5g daily dose, VERISOL® provides economical cost in use. It also boasts confirmation by now seven published VERISOL®-specific studies. VERISOL® continues to change the face of beauty by setting the benchmark in scientific substantiation, clinical efficacy and industry and consumer acceptance and confidence, propelling the beauty-from-within market forward,” she comments.

Of note, this study assures that markets with specific religious practices or ethnic norms and that prefer bovine-sourced VERISOL® have clinical confirmation that VERISOL® delivers multiple benefits to the skin, independent of the raw material type. 

It is crucial to note that the results of this study are exclusive to Gelita‘s patented VERISOL®. The results cannot be readily applied to other collagen peptides, solidifying VERISOL®’s unique standing in the beauty and skin supplement landscape. 

Click here for the full study.